DK1608654T3 - 8-substituerede-6, 7, 8, 9-tetrahydropyrimido (1,2- a) pyrimidin-4-on-derivater - Google Patents

8-substituerede-6, 7, 8, 9-tetrahydropyrimido (1,2- a) pyrimidin-4-on-derivater

Info

Publication number: DK1608654T3
Authority: DK; Denmark
Prior art keywords: tetrahydropyrimido; pyrimidin; derivatives; substituted
Prior art date: 2003-03-21

Application number

DK04721906.8T

Other languages

English (en)

Inventor

Alistair Lochead

Mourad Saady

Franck Slowinski

Philippe Yaiche

Original Assignee

Mitsubishi Tanabe Pharma Corp

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-21

Filing date

2004-03-19

Publication date

2010-04-26

2004-03-19 Application filed by Mitsubishi Tanabe Pharma Corp, Sanofi Aventis filed Critical Mitsubishi Tanabe Pharma Corp

2010-04-26 Application granted granted Critical

2010-04-26 Publication of DK1608654T3 publication Critical patent/DK1608654T3/da

Links

-1 8-substituted-6, 7, 8, 9-tetrahydropyrimido (1,2-a) pyrimidin-4-one Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Psychiatry (AREA)
Obesity (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK04721906.8T 2003-03-21 2004-03-19 8-substituerede-6, 7, 8, 9-tetrahydropyrimido (1,2- a) pyrimidin-4-on-derivater DK1608654T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03290727A EP1460075A1 (en)	2003-03-21	2003-03-21	Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
PCT/EP2004/004014 WO2004082577A2 (en)	2003-03-21	2004-03-19	8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES

Publications (1)

Publication Number	Publication Date
DK1608654T3 true DK1608654T3 (da)	2010-04-26

Family

ID=32799140

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04721906.8T DK1608654T3 (da)	2003-03-21	2004-03-19	8-substituerede-6, 7, 8, 9-tetrahydropyrimido (1,2- a) pyrimidin-4-on-derivater

Country Status (25)

Country	Link
US (2)	US7247638B2 (da)
EP (2)	EP1460075A1 (da)
JP (1)	JP4572195B2 (da)
KR (1)	KR101070149B1 (da)
CN (1)	CN100358897C (da)
AR (1)	AR043658A1 (da)
AT (1)	ATE452892T1 (da)
AU (1)	AU2004222596B2 (da)
BR (1)	BRPI0408591A (da)
CA (1)	CA2518299C (da)
CY (1)	CY1109890T1 (da)
DE (1)	DE602004024770D1 (da)
DK (1)	DK1608654T3 (da)
EA (1)	EA009197B1 (da)
ES (1)	ES2338325T3 (da)
IL (1)	IL170680A (da)
MX (1)	MXPA05010158A (da)
NO (1)	NO20054330L (da)
NZ (1)	NZ542380A (da)
PL (1)	PL1608654T3 (da)
PT (1)	PT1608654E (da)
SI (1)	SI1608654T1 (da)
TW (1)	TWI330186B (da)
WO (1)	WO2004082577A2 (da)
ZA (1)	ZA200507487B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1460075A1 (en) *	2003-03-21	2004-09-22	Sanofi-Synthelabo	Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives
JP2010500300A (ja)	2006-08-08	2010-01-07	サノフィ−アベンティス	アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
EP1939187A1 (en) *	2006-12-20	2008-07-02	Sanofi-Aventis	Substituted heteroaryl pyridopyrimidone derivatives
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2010003624A2 (en)	2008-07-09	2010-01-14	Sanofi-Aventis	Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
SG178880A1 (en)	2009-08-26	2012-04-27	Sanofi Sa	Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (de)	2010-03-03	2011-09-09	Sanofi	Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de)	2010-06-18	2018-01-24	Sanofi	Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
US8846666B2 (en)	2011-03-08	2014-09-30	Sanofi	Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120056A1 (de)	2011-03-08	2012-09-13	Sanofi	Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683698B1 (de)	2011-03-08	2017-10-04	Sanofi	Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8809324B2 (en)	2011-03-08	2014-08-19	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120055A1 (de)	2011-03-08	2012-09-13	Sanofi	Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de)	2011-03-08	2016-06-01	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683704B1 (de)	2011-03-08	2014-12-17	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2013037390A1 (en)	2011-09-12	2013-03-21	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en)	2011-09-27	2015-10-21	Sanofi	6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
BR112021002207A2 (pt)	2018-08-10	2021-05-04	Diapin Therapeutics, Llc	tri-peptídeos e tratamento de distúrbios metabólicos, cardiovasculares e inflamatórios
US11072610B2 (en)	2018-09-12	2021-07-27	Novartis Ag	Antiviral pyridopyrazinedione compounds
CN114667285B (zh)	2019-09-26	2025-08-08	诺华股份有限公司	抗病毒吡唑并吡啶酮化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1136482A1 (en) *	2000-03-23	2001-09-26	Sanofi-Synthelabo	2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors
JP2001270884A (ja) *	2000-03-23	2001-10-02	Mitsubishi-Tokyo Pharmaceuticals Inc	ピリミドン誘導体
EP1184383A1 (en) *	2000-09-01	2002-03-06	Sanofi-Synthelabo	9-[Alkyl], 9-[(heteroaryl)alkyl] and 9-[(aryl)alkyl]-2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives
DE60103909T2 (de) *	2000-09-01	2005-09-22	Sanofi-Aventis	2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
EP1460075A1 (en) *	2003-03-21	2004-09-22	Sanofi-Synthelabo	Substituted 8-Pyridinyl-6,7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 8-Phenyl-6-7,8,9-Tetrahydropyrimido[1,2-a]Pyrimidin-4-one derivatives

2003
- 2003-03-21 EP EP03290727A patent/EP1460075A1/en not_active Withdrawn
2004
- 2004-03-17 TW TW093107079A patent/TWI330186B/zh not_active IP Right Cessation
- 2004-03-19 AU AU2004222596A patent/AU2004222596B2/en not_active Ceased
- 2004-03-19 EP EP04721906A patent/EP1608654B1/en not_active Expired - Lifetime
- 2004-03-19 NZ NZ542380A patent/NZ542380A/en not_active IP Right Cessation
- 2004-03-19 WO PCT/EP2004/004014 patent/WO2004082577A2/en not_active Ceased
- 2004-03-19 CA CA2518299A patent/CA2518299C/en not_active Expired - Fee Related
- 2004-03-19 JP JP2006505152A patent/JP4572195B2/ja not_active Expired - Fee Related
- 2004-03-19 DE DE602004024770T patent/DE602004024770D1/de not_active Expired - Lifetime
- 2004-03-19 ES ES04721906T patent/ES2338325T3/es not_active Expired - Lifetime
- 2004-03-19 PL PL04721906T patent/PL1608654T3/pl unknown
- 2004-03-19 SI SI200431367T patent/SI1608654T1/sl unknown
- 2004-03-19 BR BRPI0408591-4A patent/BRPI0408591A/pt not_active IP Right Cessation
- 2004-03-19 EA EA200501315A patent/EA009197B1/ru not_active IP Right Cessation
- 2004-03-19 PT PT04721906T patent/PT1608654E/pt unknown
- 2004-03-19 MX MXPA05010158A patent/MXPA05010158A/es active IP Right Grant
- 2004-03-19 DK DK04721906.8T patent/DK1608654T3/da active
- 2004-03-19 CN CNB2004800120116A patent/CN100358897C/zh not_active Expired - Fee Related
- 2004-03-19 AR ARP040100917A patent/AR043658A1/es unknown
- 2004-03-19 AT AT04721906T patent/ATE452892T1/de active
- 2004-03-19 ZA ZA200507487A patent/ZA200507487B/en unknown
- 2004-03-19 KR KR1020057017572A patent/KR101070149B1/ko not_active Expired - Fee Related
2005
- 2005-09-05 IL IL170680A patent/IL170680A/en not_active IP Right Cessation
- 2005-09-13 US US11/225,218 patent/US7247638B2/en not_active Expired - Fee Related
- 2005-09-20 NO NO20054330A patent/NO20054330L/no not_active Application Discontinuation
2007
- 2007-06-18 US US11/764,374 patent/US8093256B2/en not_active Expired - Fee Related
2010
- 2010-03-09 CY CY20101100221T patent/CY1109890T1/el unknown

Also Published As

Publication number	Publication date
KR20050111782A (ko)	2005-11-28
ZA200507487B (en)	2006-12-27
BRPI0408591A (pt)	2006-03-21
AR043658A1 (es)	2005-08-03
IL170680A0 (en)	2009-02-11
US7247638B2 (en)	2007-07-24
JP4572195B2 (ja)	2010-10-27
CY1109890T1 (el)	2014-09-10
HK1086012A1 (en)	2006-09-08
NO20054330L (no)	2005-12-21
EP1460075A1 (en)	2004-09-22
ES2338325T3 (es)	2010-05-06
WO2004082577A2 (en)	2004-09-30
IL170680A (en)	2012-10-31
EA200501315A1 (ru)	2006-04-28
PT1608654E (pt)	2010-03-05
SI1608654T1 (sl)	2010-04-30
EA009197B1 (ru)	2007-12-28
JP2006520767A (ja)	2006-09-14
DE602004024770D1 (de)	2010-02-04
WO2004082577A3 (en)	2004-11-04
CN1784408A (zh)	2006-06-07
NZ542380A (en)	2009-01-31
US8093256B2 (en)	2012-01-10
US20080021046A1 (en)	2008-01-24
TW200504070A (en)	2005-02-01
TWI330186B (en)	2010-09-11
KR101070149B1 (ko)	2011-10-05
MXPA05010158A (es)	2006-05-19
EP1608654A2 (en)	2005-12-28
AU2004222596B2 (en)	2008-08-28
CA2518299C (en)	2011-10-25
CN100358897C (zh)	2008-01-02
PL1608654T3 (pl)	2010-07-30
US20060035885A1 (en)	2006-02-16
ATE452892T1 (de)	2010-01-15
EP1608654B1 (en)	2009-12-23
CA2518299A1 (en)	2004-09-30
NO20054330D0 (no)	2005-09-20
AU2004222596A1 (en)	2004-09-30

Publication	Publication Date	Title
NO20054330D0 (no)	2005-09-20	8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
DK1608653T3 (da)	2009-10-05	Substituerede 8-perfluoroalkyl-6,7,8,9- tetrahydropyrimido (1,2-a) pyrimidin-4-on derivater
NO2017014I1 (no)	2017-04-19	6-acetyl-8-cyclopentyl-5-metyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-on
ATE360632T1 (de)	2007-05-15	Substituierte 8'-pyri(mi)dinyl-dihydrospiro- (cycloalkylamin)-pyrimido(1,2a)pyrimidin-6- onderivate
NO20053955D0 (no)	2005-08-25	Pyrazolo [1,5-A] pyrimidinderivater
DK1611131T3 (da)	2011-01-17	Pyrazolopyridin-derivater
CY2014018I1 (el)	2015-12-09	Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
ATE309245T1 (de)	2005-11-15	5-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3- d)pyrimidin-derivate
DE60216115D1 (de)	2006-12-28	BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
NL1025068A1 (nl)	2004-06-22	Pyrrolopyrimidinederivaten.
DK1416935T3 (da)	2008-07-07	4-Amino-6-phenyl-pyrrolo[2,3-d]pyrimidinderivater
MA27043A1 (fr)	2004-12-20	Azaindoles
NO20053748D0 (no)	2005-08-04	Pyrrolopyridazinderivater.
NL1027787A1 (nl)	2005-06-21	Pyrido(2,3-d)pyrimidine-2,4-diaminen als PDE 2 remmers.
NO20043565L (no)	2004-11-25	Heteroaryl-substituerte 2-pyridinyl- og 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater.
ATE326467T1 (de)	2006-06-15	Imidazo 1,2-aöpyridine
ATE512148T1 (de)	2011-06-15	Pyrazolo- und imidazopyrimidinderivate
DK1534707T3 (da)	2008-03-25	Substituerede 2,4-dihydropyrrolo[3,4-b]quinolin-9-on-derivater egnede som phosphodiesteraseinhibitorer
NL1025932C2 (nl)	2005-11-22	3-Azabicycloó3.2.1!octaanderivaten.
NO20044405L (no)	2004-10-15	Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
SI1549647T1 (sl)	2006-10-31	Substituirani C-imidazo(1,2-a)piridin-3-il-metilamini
SI1549650T1 (sl)	2006-08-31	Substituirani C-imidazo(1,2-a)piridin-3-il-metilamini
DE602004019573D1 (de)	2009-04-02	Bohrlochschieber-transferplattform